Statement Of Cash Flows

Carna Biosciences, Inc. - Filing #7613644

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,582,110,000 JPY
-1,120,158,000 JPY
Interest paid
-4,097,000 JPY
-7,119,000 JPY
Cash flows from operating activities
Net cash provided by (used in) operating activities
-1,536,612,000 JPY
-1,260,972,000 JPY
Cash flows from operating activities
Cash flows from investing activities
Purchase of property, plant and equipment
-41,522,000 JPY
-64,737,000 JPY
Net cash provided by (used in) investing activities
-41,677,000 JPY
-70,433,000 JPY
Other, net
JPY
-1,578,000 JPY
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Proceeds from long-term borrowings
300,000,000 JPY
JPY
Repayments of long-term borrowings
-161,897,000 JPY
-270,972,000 JPY
Redemption of bonds
-28,028,000 JPY
-28,028,000 JPY
Net cash provided by (used in) financing activities
1,064,987,000 JPY
724,423,000 JPY
Other, net
-3,080,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
31,994,000 JPY
-8,931,000 JPY
Net increase (decrease) in cash and cash equivalents
-481,307,000 JPY
-615,914,000 JPY
Cash and cash equivalents
3,817,834,000 JPY
4,299,142,000 JPY
4,915,056,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.